Q1 2025 Earnings Call Transcript May 1, 2025 Chart Industries, Inc. beats earnings expectations. Reported EPS is $1.86, expectations were $1.84. Operator: Good morning, and welcome to the Chart ...

Chart Industries, Inc. ( NYSE: GTLS) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Jillian Evanko - Chief Executive Officer Joseph Brinkman - Chief Financial Officer ...

The data highlight the impact of the UNC13A genotype on clinical outcomes for amyotrophic lateral sclerosis (ALS) patients treated with NurOwn ® (debamestrocel). The presentation was featured in ...

Data from the BEXMAB study marks a significant ... The acceptance of our results for an oral presentation also represents an important company milestone, as it reflects the scientific interest ...

Mabwell (688062.SH) is an innovation-driven biopharmaceutical company with the entire value chain of the pharmaceutical industry. We provide more effective and accessible therapy and innovative ...

In the study, Shaffer and the team showed 57 doctors how a hypothetical patient's blood pressure data would change over time using two different types of graphs. One raw graph showed the actual ...

The presentation will focus on results from its ongoing open-label, randomized Phase I/II study EVICTION, including updated efficacy, safety and dose-selection data on the company’s lead γ9δ2 T-cell ...

📈📊📱💻🖥️An elegant modern declarative data visualization chart framework for iOS, iPadOS and macOS. Extremely powerful, supports line, spline, area, areaspline, column, bar, pie, scatter, angular ...

How can you use royalty-free images and video clips? From social media ads to billboards, PowerPoint presentations to feature films, you're free to modify, resize and customize every asset on iStock — ...

Candel Therapeutics announced an oral presentation of CAN-2409 data at the ASCO Annual Meeting ... stage III/IV NSCLC in patients who are resistant to first line PD-(L)1 inhibitor therapy and ...